Document:

THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE SECURITIES
LAWS. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR
OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED.

 

CONVERTIBLE SUBORDINATED PROMISSORY
NOTE

  

	$250,000	
        Note 13-1

        May 8, 2013

  

FOR VALUE RECEIVED, ProUroCare Medical Inc.,
a Nevada corporation (the “Company”), hereby promises to pay to Jeanne Rudelius (“Holder”),
the principal sum of TWO HUNDRED FIFTY THOUSAND DOLLARS ($250,000.00, together with interest as provided for herein, in
lawful currency of the United States of America.

 

SECTION 1

Terms

 

Section 1.1 Maturity.
Subject to the earlier conversion of this Convertible Subordinated Promissory Note (the “Note”), the entire
outstanding principal amount of this Note, together with the interest accrued on this Note from the date of this Note through the
date of payment, shall be payable to the Holder in cash on December 26, 2013 (the “Maturity Date”).

 

Section 1.2 Interest.
Interest shall accrue on the unpaid principal at a rate of 10.00% per annum on a 365/360 basis; that is, by applying the ratio
of the annual interest rate over a year of 360 days, multiplied by the outstanding principal balance, multiplied by the actual
number of days outstanding. Accrued interest will be paid on the Maturity Date unless the Note is prepaid pursuant to Section 1.3
or Section 1.4 or otherwise extended by agreement of the parties. This Note is made to replace two notes to the Holder that matured
on December 26, 2012. Accordingly, the interest to be accrued as stated above shall accrue beginning on December 27, 2012 through
the Maturity Date.

 

Section 1.3 Optional Conversion.
At anytime or from time to time, at the option of the Holder, all or any portion of the outstanding principal amount of this Note
(the “Converted Balance”), together with interest accrued thereon to the date of conversion, may be converted
into that number of shares of the Company’s common stock, $0.00001 par value per share (the “Common Stock”),
as is obtained by dividing the Converted Balance by $0.50 (the “Conversion Price”).

 

    	1

    	 

    

  

Section 1.4 Optional Prepayment.
Subject to the Holder’s right to have some or all of the principal on this Note converted into Common Stock in accordance
with Section 1.3 hereof, the Company will, at its option on any date subsequent to (a) the date that the closing price of the Company’s
Common Stock exceeds four dollars ($4.00) per share for ten (10) consecutive trading days or (b) the date that a strategic partner
commits to purchase all of the Notes, have the right to prepay the Notes upon thirty (30) days prior written notice to the Holder
during which time the holder may exercise their conversion rights under the terms of the Note. Any such prepayment shall be applied
first to the payment of accrued interest and then to repayment of principal. Upon any partial prepayment of the unpaid principal
amount of this Note, the Holder shall make notation on this Note of the portion of the principal so prepaid.

 

Section 1.5 Security Interest.
The term “Secured Debt” refers to the principal amount of this Note and any unpaid interest accrued thereon.
To secure the payment and performance of the Secured Debt, the Company hereby grants to the Holder a security interest in its right,
title and interest in and to the Property (as defined below), whether now existing or hereafter acquired, wherever the Property
is or will be located, and all Proceeds and products from the Property (including, but not limited to, all parts, accessories,
repairs, replacements, improvements, and accessions to the Property). “Property” is defined in Section 1.6,
and includes all obligations that support the payment or performance of the Property. “Proceeds” includes anything
acquired upon the sale, lease, license, exchange, or other disposition of the Property; any rights and claims arising from the
Property; and any collections and distributions on account of the Property.

 

The Company represents that it owns or has
rights in all of the Property. The Company has granted a security interest in the Property to secure loans from Crown Bank, and
the Holder’s security interest in the Property is subordinate to the security interest of Crown Bank, its successors or assigns
or any replacement senior secured lender (the “Senior Secured Lender”), or as otherwise disclosed in writing
to the Holder prior to any advance on the Secured Debt. The Company has also granted a security interest in the Property to the
guarantor of $200,025 of subordinated loans from Central Bank and an individual lender with respect to a $300,000 loan to the Company.
The Holder’s claim to the Property is equal in standing to the claim of the guarantor of the Central Bank loan, the individual
lender and other secured creditors who have a security interest in the Property similar to that of the Holder.

 

Section 1.6Property Description.
The Property is described as follows:

 

		(a)	Inventory. All inventory which the Company holds for ultimate sale or lease, or which has been or will be supplied under
contracts of service, or which are raw materials, work in process, or materials used or consumed in the Company’s business.

 

		(b)	Accounts and Other Rights to Payment. All rights the Company has now or in the future to payments including, but not
limited to, payment for property or services sold, leased, rented, licensed, or assigned, whether or not the Company has earned
such payment by performance. This includes any rights and interests (including all liens and security interests) which the Company
may have by law or agreement against any Account Debtor or obligor of the Company.

 

    	2

    	 

    

  

		(c)	General Intangibles. All general intangibles including, but not limited to, tax refunds, applications for patents, patents,
licenses, copyrights, trademarks, trade secrets, good will, trade names, customer lists, permits and franchises, payment intangibles,
computer programs and all supporting information provided in connection with a transaction relating to computer programs, and the
right to use the Company’s name.

 

		(d)	Equipment. All equipment including, but not limited to, all machinery, vehicles, furniture, fixtures, manufacturing
equipment, shop equipment, office and recordkeeping equipment, and parts and tools. All equipment described in a list or schedule
which the Company gives to the Holder will also be included in the Property, but such a list is not necessary for a valid security
interest in the Company’s equipment.

 

Section 1.7 No Fractional
Shares or Scrips. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this
Note. In lieu of issuing such fractional shares, the Company shall round up the number of shares to be issued to the nearest whole
share.

 

Section 1.8 No Impairment.
Without limiting or altering the provisions or obligations of the Company under this Note, the Company shall not avoid or seek
to avoid the observance or performance of any of the terms to be observed or performed by it pursuant to this Note and shall at
all times in good faith assist in the observance or performance of any of the terms to be observed or performed by it pursuant
to this Note.

 

Section 1.9 Release of Obligations.
Upon conversion or prepayment of this Note, the Company shall be forever released from all its obligations and liabilities under
this Note.

 

Section 1.10Adjustment.

 

		(a)	Adjustments for Dividends and Distributions. In the event the Company at any time or from time to time after the date
hereof shall make, issue, or fix a record date for the determination of holders of capital stock entitled to receive a dividend
or other distribution (including a stock split or subdivision) payable in securities of the Company, then and in such event provisions
shall be made so that the Holder shall receive, upon conversion of this Note, in addition to the number of shares of Common Stock
receivable thereupon, the amount of securities of the Company that the Holder would have received had this Note been converted
into Common Stock on the date of such event and had the Holder thereafter, during the period from the date of such event to and
including the conversion date, retained such securities receivable by the Holder as aforesaid during such period, giving application
to all adjustments called for during such period under this Note with respect to the rights of the Holder under the Note.

 

    	3

    	 

    

  

		(b)	Adjustment for Reclassifications, Exchanges, or Substitutions. If the Common Stock issuable upon the conversion of this
Note shall be changed into the same or different number of shares of any class or classes of capital stock, whether by capital
reorganization, reclassification, or otherwise (other than a subdivision or combination of shares or stock dividend, or a reorganization,
merger, consolidation, or sale of assets provided for elsewhere), then and in each such event the Holder shall have the right thereafter
to convert this Note into the kind and amount of shares of capital stock and other securities and property receivable upon such
reorganization, reclassification, or other change, by holders of the number of shares of Common Stock into which this Note might
have been converted immediately prior to such reorganization, reclassification or change, all subject to further adjustment as
provided herein.

 

		(c)	Reorganization; Mergers; Consolidations; Sales of Assets. If at any time or from time to time there shall be a capital
reorganization of the Common Stock issuable upon conversion of this Note (other than a subdivision, combination, reclassification,
or exchange of shares provided for elsewhere) or a merger or consolidation of the Company with or into another corporation, or
the sale of all or substantially all of the Company’s properties and assets to any other entity, then, as a part of such
reorganization, merger, consolidation, or sale, provision shall be made so that the Holder shall thereafter be entitled to receive
upon conversion of this Note, the number of shares of capital stock or other securities or property of the Company, or of the successor
corporation resulting from such merger or consolidation or sale, to which a holder of Common Stock deliverable upon conversion
would have been entitled on such capital reorganization, merger, consolidation, or sale. In any such case, appropriate adjustment
shall be made in the application of the provisions of this Note with respect to the rights of the Holder after the reorganization,
merger, consolidation, or sale to the end that the provisions of this Note shall be applicable after the event as nearly equivalent
as may be practicable.

 

		(d)	Adjustment for Stock Splits and Combinations. If the Company at any time or from time to time effects a subdivision
of the outstanding capital stock, the Conversion Price then in effect immediately before that subdivision shall be proportionately
decreased, and conversely, if the Company at any time or from time to time combines the outstanding shares of capital stock, the
Conversion Price then in effect immediately before the combination shall be proportionately increased. Any adjustment under this
subsection (d) shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

SECTION 2

Restrictions of Transfer

 

Section 2.1No Transfer.
No transfer of this Note may be completed unless and until (i) the Company has received an opinion of counsel for the Company that
such securities may be sold pursuant to an exemption from registration under the Securities Act of 1933, as amended (the "Securities
Act"), or (ii) a registration statement relating to this Note has been filed by the Company and declared effective by
the Commission. Subject to the foregoing, this Note and all rights hereunder are transferable, in whole or in part, at the principal
office of the Company by the Holder in person or by duly authorized attorney, upon surrender of this Note properly endorsed to
any person or entity who represents in writing that he/she/it is acquiring the Note for investment and without any view to the
sale or other distribution thereof. Each Holder of this Note, by taking or holding the same, consents and agrees that the bearer
of this Note, when endorsed, may be treated by the Company and all other persons dealing with this Note as the absolute owner hereof
for any purpose and as the person entitled to exercise the rights represented by this Note or perform the obligations required
hereby, or to the transfer hereof on the books of the Company, any notice to the contrary notwithstanding; but until such transfer
on such books, the Company may treat the registered owner hereof as the owner for all purposes.

 

    	4

    	 

    

  

Section 2.2 Legend. Each
certificate for Common Stock issued upon the conversion of this Note shall bear a legend as follows unless, in the opinion of counsel
to the Company, such legend is not required in order to ensure compliance with the Securities Act:

 

"THE SECURITIES EVIDENCED
BY THIS CERTIFICATE WERE ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE
STATE SECURITIES LAWS, AND IN RELIANCE UPON THE HOLDER’S REPRESENTATION THAT SUCH SECURITIES WERE BEING ACQUIRED FOR INVESTMENT
AND NOT FOR RESALE. NO TRANSFER OF THE SECURITIES MAY BE MADE ON THE BOOKS OF THE COMPANY UNLESS (i) SUCH TRANSFER IS MADE PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS OR (ii)
UNLESS THE HOLDER SHALL HAVE PROVIDED THE COMPANY WITH AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE COMPANY TO THE EFFECT
THAT NO SUCH REGISTRATION IS REQUIRED."

 

SECTION 3

Events of Default

 

Section 3.1 Events of Default.
The entire outstanding principal amount of this Note, together with all interest accrued thereon (such principal and accrued interest,
the “Outstanding Balance”) shall become due and payable without any action on the part of the Holder thereof
upon the happening of any of the following events (each, an “Event of Default”):

 

		(a)	the Company shall generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its
debts generally, or shall make a general assignment for the benefit of creditors; or any proceeding shall be instituted by or against
the Company seeking to adjudicate it bankrupt or insolvent, or seeking liquidation, winding up, reorganization, arrangement, adjustment,
custodianship, protection, or relief of it or its debts under any law relating to bankruptcy, insolvency or reorganization or relief
of debtors, or seeking the entry of an order for relief or the appointment of a receiver, custodian trustee, or other similar official
for it or for any substantial part of its property; or

 

    	5

    	 

    

  

		(b)	the Company shall default in the due performance or observance of any expressed or implied covenant, agreement or provision
of this Note and such default shall have continued uncured for a period of sixty (60) days after written notice thereof to the
Company from the Holder.

 

Section 3.2Suits for
Enforcement. In case any one or more Events of Default shall have occurred and be continuing, unless such Events of Default
shall have been waived in the manner provided in Section 4.6, the Holder may proceed to protect and enforce his rights under this
Section 3 by suit in equity or action at law. It is agreed that in the event the Holder prevails in such action, the Holder shall
be entitled to receive all reasonable fees, costs and expenses incurred, including without limitation such reasonable fees and
expenses of attorneys (whether or not litigation is commenced) and reasonable fees, costs and expenses of appeals.

 

SECTION 4

Miscellaneous

 

Section 4.1 No rights as
Shareholder. This Note shall not entitle the Holder to any voting rights or other rights as a shareholder of the Company.

 

Section 4.2 Lost, Stolen
or Mutilated Notes. Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this
Note, and in case of any such loss, theft or destruction, upon delivery of any customary indemnity agreement reasonably satisfactory
to the Company, or in any case of any such mutilation, upon surrender and cancellation of this Note, the Company at its expense
will issue and deliver a new Note of like tenor in an amount equal to the amount of such lost, stolen or mutilated Note and any
such lost, stolen or destroyed Note shall thereupon become void.

 

Section 4.3 Benefit of Note.
This Note shall be binding upon, and shall inure to the benefit of and be enforceable by, the Holder and his successors and assigns.
All of the covenants and the agreements contained in this Note by or on behalf of the Company are binding on the Company’s
successors and assigns, whether by consolidation, merger, transfer or license of all or substantially all of the property of the
Company.

 

Section 4.4 Costs of Collection.
The Company hereby waives presentment for payment, notice of dishonor, protest and notice of protest and, following an Event of
Default, the Company shall pay all of the Holder’s costs of collecting or attempting to collect any amount due hereunder,
including but not limited to, all reasonable attorneys’ fees and legal expenses.

 

Section 4.5 Notices.
All notices required under this Note shall be deemed to have been given or made for all purposes (i) upon personal delivery,
(ii) upon confirmation receipt that the communication was successfully sent to the applicable number if sent by facsimile;
(iii) one day after being sent, when sent by professional overnight courier service, or (iv) five days after posting
when sent by registered or certified mail. Notices to the Company shall be sent to the principal office of the Company (or at such
other place as the Company shall notify the Holder hereof in writing). Notices to the Holder shall be sent to the address of the
Holder as set forth in the books and records of the Company on the date hereof (or at such other place as the Holder shall notify
the Company hereof in writing).

 

    	6

    	 

    

  

Section 4.6 Amendment; Waiver.
Any term of this Note may be amended, changed or modified, and the observance of any term of this Note may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Holder

 

Section 4.7 Governing Law
and Construction. This Note shall be construed in accordance with and governed by the laws of the State of Minnesota, without
regard to the principles of conflicts of law. Whenever possible, each provision of this Note and any other statement, instrument
or transaction contemplated hereby and valid under such applicable law, but, if any provision of this Note or any other statement,
instrument or transaction contemplated hereby or relating hereto shall be held to be prohibited or invalid under such applicable
law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder
of such provision or the remaining provisions of this Note or any other statement, instrument or transaction contemplated hereby
or relating hereto.

 

IN WITNESS WHEREOF, the Company has
executed this Note as of the date first above written.

 

	 	PROUROCARE MEDICAL INC.
	 	 	 
	 	By:	/s/ Stan Myrum
	 	 	Name: Stan Myrum
	 	 	Title: Chief Executive Officer

 

    	7CONSULTING AGREEMENT

 

This Agreement made by and between ProUroCare
Medical Inc., with a place of business at 6440 Flying Cloud Drive, Suite 101, Eden Prairie, Minnesota 55344 (“PUC”),
and Stan Myrum d/b/a LHG Consulting, Inc., with an address at 7348 Xene Lane North, Maple Grove, Minnesota 55311 (“Consultant”),
this 8th day of May, 2013, with terms effective as of April 23, 2013;

 

WHEREAS, PUC wishes to avail itself, under
the terms of this Agreement, of the services of Consultant;

 

WHEREAS, Consultant is agreeable, under
the terms of this Agreement, to provide services to PUC;

 

NOW, THEREFORE, the parties agree as follows:

 

		I.	Duties

 

		A.	Consultant shall provide services to PUC as its interim Chief Executive Officer (“CEO”). Consultant, as PUC’s
CEO, shall direct PUC’s strategic initiatives, oversee its operations, manage its relationships with potential strategic
partners, inventors and participate in the recruitment of a full-time CEO and other reasonable duties requested by PUC’s
Board of Directors.

 

		B.	All such services shall be rendered at such times as are agreed to between PUC and the Consultant and shall be subject to the
reasonable conflicting scheduling obligations of the Consultant.

 

		II.	Compensation

 

		A.	In consideration for Consultant’s services under this Agreement, PUC shall pay Consultant as follows:

 

		1.	Consultant shall be paid at the rate of one hundred dollars ($100.00) per hour. Consultant shall prepare a monthly statement
identifying the services provided and the hours spent providing such services and PUC shall pay such statement within thirty (30)
days of its receipt, unless making such payment would seriously jeopardize PUC’s ability to meet the milestones needed to
obtain FDA clearance to commercialize its ProUroScan device, in which case payment shall be made as soon thereafter as reasonably
feasible; and

    	 

    	 

    

 

		2.	Consultant shall be provided a commitment fee of one hundred fifty thousand (150,000) warrants to purchase common stock of
PUC. The warrants shall vest upon the first to occur of a) PUC’s first commercialization of its ProUroScan device, defined
as a first sale, lease, procedure payment or other activity in which monies are received by PUC but excluding any placements at
KOL sites for post-market studies, or b) a Change in Control of PUC, as defined in Section XIII herein. The warrants may be exercised
on a cashless basis for five (5) years after they vest at an exercise price of fifty cents ($0.50) per share.

 

		B.	PUC will reimburse Consultant in accordance with its normal reimbursement policy for reasonable travel and other expenses incurred
at PUC’s request in carrying out the Consultant’s duties under this Agreement. Reimbursement for approved expenses
will be made within thirty (30) days of receipt from the Consultant of an itemized expense report.

 

		III.	D&O Insurance

 

In consideration for Consultant agreeing
to perform the duties as CEO of PUC, PUC agrees to secure and maintain D&O insurance of a type and in an amount typically obtained
by companies similarly situated to PUC to protect Consultant from liability incurred as a result of Consultant’s performance
of his duties as CEO of PUC. Additionally, PUC agrees to indemnify and hold harmless Consultant from and against all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs
and reasonable attorney’s fees which Consultant may suffer as a result of or relating to Consultant’s activities as
CEO of PUC, unless Consultant’s actions constitute fraud, gross negligence, willful misconduct or malfeasance.

 

		IV.	Confidentiality

 

Consultant acknowledges that in the performance
of Consultant’s work hereunder Consultant may obtain access to Confidential Information (as defined below) of PUC. Consultant
agrees, during and for five (5) years from the date of expiration or termination of this Agreement, to (a) retain in confidence
and not disclose to any third party and (b) use only for the purpose of carrying out Consultant’s work and services hereunder,
any such Confidential Information. As used herein Confidential Information means any technical or non-technical information or
data in written, oral or tangible form (including samples, models and prototypes) relating to PUC’s business or potential
business operations or with respect to PUC’s research and development activities (including but not limited to new products
or accessories, not generally available to or known to the public) that is disclosed to Consultant by or on behalf of PUC, or learned
by Consultant pursuant to Consultant’s work hereunder. Furthermore, any technical or non-technical information or data developed
or generated in whole or in part by Consultant pursuant to Consultant work hereunder (including without limitation any reports
prepared by Consultant) shall be deemed Confidential Information. Upon completion of Consultant’s work hereunder or other
termination of this Agreement, Consultant will return to PUC, as and if requested by PUC, all documents (including all copies thereof)
and all tapes or other embodiments of information or data in each case containing or constituting Confidential Information disclosed
to or generated by Consultant in connection with this Agreement as well as samples, models or prototypes supplied by PUC.

 

    	2

    	 

    

 

		V.	Ideas/Assignments

 

		A.	During the term of this Agreement, it is contemplated that Consultant may generate ideas, inventions, improvements or suggestions,
whether or not patentable (“Ideas”) connected with the delivery of services and the performance of duties under this
Agreement. If an Idea is generated from the services provided and duties performed under this Agreement by Consultant, irrespective
of whether such Idea is made alone or in conjunction with others at PUC or elsewhere, Consultant agrees to disclose such Idea and
assign it to PUC in a form satisfactory to its Counsel. Any such Ideas shall be deemed as “works made for hire” unless
applicable law requires otherwise.

 

		B.	Consultant further agrees to render assistance as PUC may require to perfect such assignment and to execute any documents required
to publish, patent or protect such Idea in any patent office or in litigation. Following expiration or termination of this Agreement,
Consultant agrees to provide such assistance, as may be reasonably requested by PUC, at Consultant’s then prevailing hourly
consulting rate.

 

		C.	Any Ideas which Consultant believes to be proprietary or confidential to him/her, if disclosed to PUC shall be deemed as “works
made for hire” unless disclosed under a separate agreement which is crafted to preserve the confidentiality and any proprietary
rights Consultant may have to the Idea.

 

		VI.	Copyrightable Materials

 

Copyrightable materials that Consultant
develops under this Agreement shall be the property of PUC. Consultant agrees to assign such copyrightable materials to PUC and
to sign any documents required by applicable copyright statutes in this or any other country. These copyrightable materials shall
be deemed as “works made for hire” unless applicable law requires otherwise.

 

		VII.	Conflict of Interest

 

During the period of this Agreement, Consultant
will not serve as a Consultant or provide services or perform duties for any third party within the Field of Prostate Cancer Diagnostic
Products and Services or enter into any other agreement inconsistent with any term of this Agreement unless specifically agreed
to in writing by the Board of Directors of PUC. Consultant shall, however, be permitted to act as a consultant and/or provide services
to third parties on terms not inconsistent with any term of this Agreement.

 

		VIII.	Independent Contractor

 

		A.	It is expressly understood and agreed that for all purposes, including but not limited to workers’ compensation insurance,
unemployment insurance, FICA, and federal and state tax withholding, Consultant shall be deemed to be an independent contractor
and not an employee of PUC. As such, Consultant shall not be entitled to the benefits that PUC provides to its employees.

 

    	3

    	 

    

 

		B.	Conduct and control of the work performed under this Agreement by Consultant or Consultant’s agents or employees lies
solely with Consultant.

 

		C.	In the event PUC is liable for any withholding taxes, unemployment compensation or workers’ compensation associated with
Consultant’s performance of this Agreement, Consultant agrees to indemnify PUC for all such payments paid or payable on Consultants’
behalf.

 

		IX.	General Provisions

 

		A.	This Agreement represents the only Agreement relating to this subject matter between the parties hereto. All past or contemporaneous
discussions, agreements, understandings, or proposals, whether oral or written, are superseded by this Agreement.

 

		B.	If any part of this Agreement is unenforceable, that will not affect any other part. This Agreement will be read as if the
unenforceable parts were omitted.

 

		C.	This Agreement shall be construed and interpreted under and in accordance with the laws of the State of Minnesota, United States
of America.

 

		D.	No modifications to this Agreement can be made except in writing, signed by Consultant and PUC.

 

		E.	This Agreement may be executed in one or more counterpart copies, each of which shall have the same force and effect as an
original.

 

		F.	No rights or obligations under this Agreement may be assigned or subcontracted by any party without the prior written consent
of the other party. Any such attempted assignment or subcontract is void.

 

		X.	Duration of Agreement

 

		A.	This Agreement is effective as of the date first above written and shall continue in effect until July 31, 2013 (the “Initial
Period”). Thereafter, unless one party gives the other notice of its desire to have this Agreement expire, it shall be automatically
renewed for additional periods of two (2) months each on the same terms as set forth herein, except that Consultant shall be entitled
to a bonus payment as follows for each such renewal (the “Bonus”). The Bonus shall be as mutually agreed upon by Consultant
and the Board of Directors of PUC. The above notwithstanding, either party may terminate this Agreement with or without cause at
any time by giving thirty (30) days’ written notice to the other party.

 

    	4

    	 

    

 

		B.	The terms of Section IV on Confidentiality, and Section V on Ideas/Assignments, and Section XII on Use of Consultant’s
Name shall survive the expiration or early termination of this Agreement.

 

		XI.	Binding Arbitration

 

Any dispute related to this Agreement between
the Consultant and PUC, including its formation, performance, or termination, which cannot be resolved within a reasonable time,
may be referred by any of the parties to binding arbitration in accordance with the Rules for Non-Administered Arbitration of Business
Disputes of the Center for Public Resources, Inc., in effect as of the date of this Agreement. Such arbitration, which the parties
intend to substitute for litigation, shall occur in Minneapolis, Minnesota, and the arbitration results may be entered as a final
judgment in a court with jurisdiction. Such arbitration shall be governed by the Federal Arbitration Act (9 U.S.C. Section 1-16
et seq.). All parties shall be responsible for their own costs and fees (including attorney’s fees), and shall divide common
costs and fees equally. Any contrary provisions of the United States Arbitration Act notwithstanding, the parties expressly stipulate
and agree that the arbitrator is not empowered to award damages in excess of actual damages; punitive, exemplary or treble damages
are expressly agreed to be beyond the powers conferred upon the arbitrator. The parties further agree that the award rendered by
the arbitrator shall not constitute a basis for collateral estoppel as to any issue.

 

		XII.	Use of Consultant’s Name

 

Consultant consents to the use of the Consultant’s name,
without prior written approval, in appropriate PUC materials such as, but not limited to, PUC publications, press releases, SEC
filings, and offering memoranda.

 

		XIII.	Change in Control

 

For Purposes of this Agreement, a “Change in Control”
is defined as follows:

 

		(i)	When any “person” as defined in Section 3(a)(9) of the Securities Exchange Act as used
in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) of the Securities Exchange Act,
but excluding PUC or any subsidiary or parent or any Executive benefit plan sponsored or maintained by PUC or any subsidiary or
parent (including any trustee of such plan acting as trustee), directly or indirectly, becomes the “beneficial owner”
(as defined in Rule 13d-3 under the Securities Exchange Act, as amended from time to time) of securities of PUC representing greater
than fifty (50) percent of the combined voting power of PUC’s then outstanding securities; or,

 

		(ii)	PUC is party to a merger or consolidation, or series of related transactions, which results in the voting securities of PUC
outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into
voting securities of the surviving or another entity) at least fifty (50%) percent of the combined voting power of the voting securities
of PUC or such surviving or other entity outstanding immediately after such merger or consolidation;

 

    	5

    	 

    

 

		(iii)	the sale or disposition of all or substantially all of PUC’s assets (or consummation of any transaction, or series of
related transactions, having similar effect);

 

		(iv)	the dissolution or liquidation of PUC; or

 

		(v)	any transaction or series of related transactions that has the substantial effect of any one or more of the foregoing.

 

	PROUROCARE MEDICAL INC.	 	CONSULTANT
	 	 	 	 	 
	By	/s/ Robert J. Rudelius	 	By	/s/ Stan Myrum
	 	 	 	 	 
	Title	Vice-Chairman	 	Title	President
	 	 	 	 	 
	Date	May 8, 2013	 	Date	May 8, 2013

 

    	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}]]